Cancer Prevention II

  • Hans-Jörg Senn
  • Ursula Kapp
  • Florian Otto
Conference proceedings

DOI: 10.1007/978-3-540-69297-3

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 181)

Table of contents (22 papers)

  1. Front Matter
    Pages i-xx
  2. Cancer Prevention and Health Politics

    1. Do We Make Optimal Use of the Potential of Cancer Prevention?
      Peter Greenwald, Barbara K. Dunn
      Pages 3-17
    2. Predictors of Successful Cancer Prevention Programs
      Franz Porzsolt, Anita Kirner, Robert M. Kaplan
      Pages 19-31
    3. Is Cancer Prevention Ever Going to Be Profitable?
      Thomas D. Szucs, Konstantin J. Dedes
      Pages 41-47
  3. Cancer Prevention: The Scientific-Epidemiological Base

    1. Promises and Limitations of Biomarkers
      David F. Ransohoff
      Pages 55-59
  4. Cancer Prevention, Tobacco and Nutrition

    1. The EPIC Study: An Update
      Paolo Vineis, Elio Riboli
      Pages 63-70
    2. Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
      Ilaria Sogno, Roberta Venè, Cristina Sapienza, Nicoletta Ferrari, Francesca Tosetti, Adriana Albini
      Pages 71-76
    3. Retinoids and Breast Cancer Prevention
      Bernardo Bonanni, Matteo Lazzeroni
      Pages 77-81
  5. Cancer Prevention, Genetics and Vaccines

  6. Cancer Prevention and Target Organs I: Breast Cancer

    1. Energy Restriction for Breast Cancer Prevention
      Anthony Howell, Mary Chapman, Michelle Harvie
      Pages 97-111
    2. The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer
      D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Walter M. Cronin, Reena S. Cecchini, Leslie G. Ford et al.
      Pages 113-119
    3. Prevention of ER-Negative Breast Cancer
      Yuxin Li, Powel H. Brown
      Pages 121-134
  7. Cancer Prevention and Target Organs II: Cancer of the Digestive Tract

    1. Chemoprevention of Oesophageal Cancer and the AspECT Trial
      Debasish Das, Andrew P. Chilton, Janusz A. Jankowski
      Pages 161-169
  8. Cancer Prevention and Target Organs III: Prostate Cancer

    1. Review of Diagnostic Markers for Prostate Cancer 16
      Fritz H. Schröder
      Pages 173-182
    2. Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
      Ilaria Sogno, Nicola Vannini, Girieca Lorusso, Rosaria Cammarota, Douglas M. Noonan, Luca Generoso et al.
      Pages 209-212

About these proceedings

Introduction

More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy of Early Breast Cancer” as well as “Supportive Care in Cancer” for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today’s medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland—and we fear in many other parts of the globe—some 97%–98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%–3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for “curing and caring” for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population.

Keywords

ER-negative breast cancer Prevention of breast cancer Primary prevention cancer prevention chemoprevention prevention

Editors and affiliations

  • Hans-Jörg Senn
    • 1
  • Ursula Kapp
    • 1
  • Florian Otto
    • 1
  1. 1.Zentrum fücr Tumordiagnostik und PräventionSt. GallenSchweiz

Bibliographic information

  • Copyright Information Springer Berlin Heidelberg 2009
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-540-69296-6
  • Online ISBN 978-3-540-69297-3
  • Series Print ISSN 0080-0015